Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl A C Peretz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|June 5, 2025
SNACS: a tool for demultiplexing single-cell DNA sequencing dataVanessa E Kennedy, Ritu Roy, Cheryl A C Peretz, et al.
Nature Communications|March 12, 2021
Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemiaBenjamin Demaree, Cyrille L Delley, Harish N Vasudevan, et al.
American Journal of Hematology|October 10, 2023
The FLT3<sup>N701K</sup> mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinibSunil K Joshi, Janét Pittsenbarger, Vanessa E Kennedy, et al.
Blood Advances|March 5, 2021
Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinibCheryl A C Peretz, Lisa H F McGary, Tanya Kumar, et al.
European Journal of Haematology|April 28, 2026
Multiomic Single-Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AMLVanessa E Kennedy, Cheryl A C Peretz, Andrew Koh, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid LeukemiaBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Cell Reports. Medicine|November 22, 2023
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AMLBogdan Popescu, Carlos Stahlhut, Theodore C Tarver, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk StratificationCheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, et al.
Blood|October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AMLBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Cancer Discovery|May 16, 2019
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M McMahon, Timothy Ferng, Jonathan Canaani, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|June 5, 2025
SNACS: a tool for demultiplexing single-cell DNA sequencing dataVanessa E Kennedy, Ritu Roy, Cheryl A C Peretz, et al.
Nature Communications|March 12, 2021
Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemiaBenjamin Demaree, Cyrille L Delley, Harish N Vasudevan, et al.
American Journal of Hematology|October 10, 2023
The FLT3<sup>N701K</sup> mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinibSunil K Joshi, Janét Pittsenbarger, Vanessa E Kennedy, et al.
Blood Advances|March 5, 2021
Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinibCheryl A C Peretz, Lisa H F McGary, Tanya Kumar, et al.
European Journal of Haematology|April 28, 2026
Multiomic Single-Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AMLVanessa E Kennedy, Cheryl A C Peretz, Andrew Koh, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid LeukemiaBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Cell Reports. Medicine|November 22, 2023
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AMLBogdan Popescu, Carlos Stahlhut, Theodore C Tarver, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk StratificationCheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, et al.
Blood|October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AMLBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Cancer Discovery|May 16, 2019
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M McMahon, Timothy Ferng, Jonathan Canaani, et al.
Pageof 2